INTERSCIENCE BELGIUM: what changed
What changed
INTERSCIENCE BELGIUM
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€802,320
2024 · €793,305+€9,015
Equity
€1.5m
2024 · €1.6m-€47,427
Cash
€836,920
2024 · €620,960+€215,960
Balance sheet total
€5.7m
2024 · €6.3m-€595,881
Largest movements
Assets
- Receivables within one year -€799,293
down €799,293 (-21.4%), from €3.7m to €2.9m
of which Trade receivables: -€835,832
- Cash +€215,960
up €215,960 (+34.8%), from €620,960 to €836,920
mainly Net result for the year (+€802,320) and Receivables within one year (+€799,293)
- Tangible fixed assets -€155,358
down €155,358 (-22.0%), from €706,950 to €551,593
of which Furniture and vehicles: -€120,434
- Stocks and contracts +€114,078
up €114,078 (+9.5%), from €1.2m to €1.3m
Equity and liabilities
- Trade debts -€356,830
down €356,830 (-22.1%), from €1.6m to €1.3m
- Accrued charges and deferred income -€160,426
down €160,426 (-13.4%), from €1.2m to €1.0m
- Tax, wage and social debts -€145,460
down €145,460 (-17.5%), from €828,889 to €683,428
of which Taxes: -€186,384
- Other debts +€113,208
up €113,208 (+15.5%), from €732,295 to €845,503
Income statement
- Staff costs +€91,448
up €91,448 (+4.0%), from €2.3m to €2.4m
- Provisions -€50,718
down €50,718 (-97.9%), from €51,802 to €1,084
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€793,305
Gross operating margin
-€4,814
Staff costs
-€91,448
Depreciation
+€10,483
Write-downs
+€10,376
Provisions
+€50,718
Other operating charges
+€21,413
Financial income
+€27,887
Financial charges
+€2,346
Taxes
-€17,947
Result 2025
€802,320
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€1.1m
Investment
-€20,135
Financing
-€849,747
Cash 2024
€620,960
From operations (derived)
+€1.1m
Net result for the year
+€802,320
Depreciation
+€175,493
Stocks and contracts
-€114,078
Receivables within one year
+€799,293
Deferred charges and accrued income
-€28,732
Smaller working-capital items
+€1,055
Trade debts
-€356,830
Tax, wage and social debts
-€145,460
Other debts
+€113,208
Accrued charges and deferred income
-€160,426
Investment (derived)
-€20,135
Investment in fixed assets (net)
-€20,135
Financing
-€849,747
Contributions, distributions and other
-€849,747
Cash 2025
€836,920
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,265,712 | €5,669,831 | -€595,881 | -9.5% |
| Fixed assets | 21/28 | €707,264 | €551,907 | -€155,358 | -22.0% |
| Tangible fixed assets | 22/27 | €706,950 | €551,593 | -€155,358 | -22.0% |
| Land and buildings | 22 | €351,080 | €316,156 | -€34,924 | -9.9% |
| Furniture and vehicles | 24 | €355,870 | €235,437 | -€120,434 | -33.8% |
| Financial fixed assets | 28 | €314 | €314 | = | 0.0% |
| Current assets | 29/58 | €5,558,448 | €5,117,925 | -€440,523 | -7.9% |
| Stocks and contracts in progress | 3 | €1,202,493 | €1,316,571 | +€114,078 | +9.5% |
| Stocks | 30/36 | €1,202,493 | €1,316,571 | +€114,078 | +9.5% |
| Amounts receivable within one year | 40/41 | €3,732,011 | €2,932,718 | -€799,293 | -21.4% |
| Trade receivables | 40 | €3,609,981 | €2,774,149 | -€835,832 | -23.2% |
| Other amounts receivable | 41 | €122,030 | €158,569 | +€36,539 | +29.9% |
| Current investments | 50/53 | €0 | - | = | |
| Cash at bank and in hand | 54/58 | €620,960 | €836,920 | +€215,960 | +34.8% |
| Deferred charges and accrued income | 490/1 | €2,983 | €31,715 | +€28,732 | +963% |
| Total equity and liabilities | 10/49 | €6,265,712 | €5,669,831 | -€595,881 | -9.5% |
| Equity | 10/15 | €1,584,045 | €1,536,618 | -€47,427 | -3.0% |
| Contributions | 10/11 | €19,831 | €19,831 | = | 0.0% |
| Reserves | 13 | €1,564,213 | €1,516,786 | -€47,427 | -3.0% |
| Tax-exempt reserves | 132 | €1,892 | €1,743 | -€149 | -7.9% |
| Distributable reserves | 133 | €1,562,321 | €1,515,043 | -€47,278 | -3.0% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Provisions and deferred taxes | 16 | €302,575 | €303,598 | +€1,023 | +0.3% |
| Provisions for liabilities and charges | 160/5 | €301,802 | €302,886 | +€1,084 | +0.4% |
| Other liabilities and charges | 164/5 | €301,802 | €302,886 | +€1,084 | +0.4% |
| Deferred taxes | 168 | €773 | €712 | -€61 | -7.9% |
| Amounts payable | 17/49 | €4,379,092 | €3,829,615 | -€549,477 | -12.5% |
| Amounts payable within one year | 42/48 | €3,178,324 | €2,789,273 | -€389,051 | -12.2% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Trade debts | 44 | €1,617,135 | €1,260,304 | -€356,830 | -22.1% |
| Suppliers | 440/4 | €1,617,135 | €1,260,304 | -€356,830 | -22.1% |
| Advances received on contracts in progress | 46 | €6 | €37 | +€32 | +562% |
| Taxes, remuneration and social security | 45 | €828,889 | €683,428 | -€145,460 | -17.5% |
| Taxes | 450/3 | €443,607 | €257,224 | -€186,384 | -42.0% |
| Remuneration and social security | 454/9 | €385,281 | €426,205 | +€40,923 | +10.6% |
| Other amounts payable | 47/48 | €732,295 | €845,503 | +€113,208 | +15.5% |
| Accrued charges and deferred income | 492/3 | €1,200,768 | €1,040,342 | -€160,426 | -13.4% |
| Remuneration, social security and pensions | 62 | €2,313,359 | €2,404,807 | +€91,448 | +4.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €185,976 | €175,493 | -€10,483 | -5.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €20,320 | €9,943 | -€10,376 | -51.1% |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €51,802 | €1,084 | -€50,718 | -97.9% |
| Other operating charges | 640/8 | €44,892 | €23,479 | -€21,413 | -47.7% |
| Gross operating margin | 9900 | €3,682,112 | €3,677,298 | -€4,814 | -0.1% |
| Operating profit (loss) | 9901 | €1,065,763 | €1,062,492 | -€3,271 | -0.3% |
| Financial income | 75/76B | €46,783 | €74,669 | +€27,887 | +59.6% |
| Recurring financial income | 75 | €46,783 | €74,669 | +€27,887 | +59.6% |
| Financial charges | 65/66B | €27,082 | €24,736 | -€2,346 | -8.7% |
| Recurring financial charges | 65 | €27,082 | €24,736 | -€2,346 | -8.7% |
| Profit (loss) for the period before taxes | 9903 | €1,085,464 | €1,112,426 | +€26,962 | +2.5% |
| Transfer from deferred taxes | 780 | €61 | €61 | = | 0.0% |
| Income taxes | 67/77 | €292,220 | €310,166 | +€17,947 | +6.1% |
| Profit (loss) for the period | 9904 | €793,305 | €802,320 | +€9,015 | +1.1% |
| Transfer from tax-exempt reserves | 789 | €149 | €149 | = | 0.0% |
| Profit (loss) for the period to be appropriated | 9905 | €793,455 | €802,470 | +€9,015 | +1.1% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.